BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 11718666)

  • 1. Cargo delivery kinetics of cell-penetrating peptides.
    Hällbrink M; Florén A; Elmquist A; Pooga M; Bartfai T; Langel U
    Biochim Biophys Acta; 2001 Dec; 1515(2):101-9. PubMed ID: 11718666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides.
    Ishihara T; Goto M; Kodera K; Kanazawa H; Murakami Y; Mizushima Y; Higaki M
    Drug Deliv; 2009 Apr; 16(3):153-9. PubMed ID: 19514975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study.
    El-Andaloussi S; Järver P; Johansson HJ; Langel U
    Biochem J; 2007 Oct; 407(2):285-92. PubMed ID: 17627607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocation properties of novel cell penetrating transportan and penetratin analogues.
    Lindgren M; Gallet X; Soomets U; Hällbrink M; Bråkenhielm E; Pooga M; Brasseur R; Langel U
    Bioconjug Chem; 2000; 11(5):619-26. PubMed ID: 10995204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passage of cell-penetrating peptides across a human epithelial cell layer in vitro.
    Lindgren ME; Hällbrink MM; Elmquist AM; Langel U
    Biochem J; 2004 Jan; 377(Pt 1):69-76. PubMed ID: 12968950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internalisation of cell-penetrating peptides into tobacco protoplasts.
    Mäe M; Myrberg H; Jiang Y; Paves H; Valkna A; Langel U
    Biochim Biophys Acta; 2005 May; 1669(2):101-7. PubMed ID: 15893512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
    Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
    Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein and siRNA delivery by transportan and transportan 10 into colorectal cancer cell lines.
    Wierzbicki PM; Kogut-Wierzbicka M; Ruczynski J; Siedlecka-Kroplewska K; Kaszubowska L; Rybarczyk A; Alenowicz M; Rekowski P; Kmiec Z
    Folia Histochem Cytobiol; 2014; 52(4):270-80. PubMed ID: 25511292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos.
    Chugh A; Eudes F
    FEBS J; 2008 May; 275(10):2403-14. PubMed ID: 18397318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein cargo delivery properties of cell-penetrating peptides. A comparative study.
    Säälik P; Elmquist A; Hansen M; Padari K; Saar K; Viht K; Langel U; Pooga M
    Bioconjug Chem; 2004; 15(6):1246-53. PubMed ID: 15546190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro: implications for continued therapeutic use.
    Carter E; Lau CY; Tosh D; Ward SG; Mrsny RJ
    Eur J Pharm Biopharm; 2013 Sep; 85(1):12-9. PubMed ID: 23958314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the interaction, positioning, structure induction and membrane perturbation of cell-penetrating peptides and non-translocating variants with phospholipid vesicles.
    Magzoub M; Eriksson LE; Gräslund A
    Biophys Chem; 2003 Mar; 103(3):271-88. PubMed ID: 12727289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-penetrating peptides: tools for intracellular delivery of therapeutics.
    Deshayes S; Morris MC; Divita G; Heitz F
    Cell Mol Life Sci; 2005 Aug; 62(16):1839-49. PubMed ID: 15968462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural polymorphism of two CPP: an important parameter of activity.
    Deshayes S; Decaffmeyer M; Brasseur R; Thomas A
    Biochim Biophys Acta; 2008 May; 1778(5):1197-205. PubMed ID: 18316038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of cell-penetrating peptide-mediated peptide delivery.
    Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
    Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosaminoglycans are required for translocation of amphipathic cell-penetrating peptides across membranes.
    Pae J; Liivamägi L; Lubenets D; Arukuusk P; Langel Ü; Pooga M
    Biochim Biophys Acta; 2016 Aug; 1858(8):1860-7. PubMed ID: 27117133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates.
    Eiríksdóttir E; Mäger I; Lehto T; El Andaloussi S; Langel U
    Bioconjug Chem; 2010 Sep; 21(9):1662-72. PubMed ID: 20684543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell transduction pathways of transportans.
    Padari K; Säälik P; Hansen M; Koppel K; Raid R; Langel U; Pooga M
    Bioconjug Chem; 2005; 16(6):1399-410. PubMed ID: 16287236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells.
    Chugh A; Eudes F; Shim YS
    IUBMB Life; 2010 Mar; 62(3):183-93. PubMed ID: 20101631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling.
    Kilk K; Mahlapuu R; Soomets U; Langel U
    Toxicology; 2009 Nov; 265(3):87-95. PubMed ID: 19799958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.